Dr Juan Carlos Hernández-Boluda graduated in Medicine in 1994 at the University of Valencia. He was a resident in the Hematology Service of the Hospital Clínic of Barcelona (1995-1998), where he earned his PhD in Medicine and Surgery with a doctoral thesis entitled: "Role of p16 and survivin in the progression of chronic myeloid leukemia from the chronic phase to the blast crisis" (2005). Since 2001, he has been an Associated Physician at the Hematology Department of the Hospital Clínico Universitario of Valencia, working primarily in the fields of hematopoietic stem cell transplantation and the chronic myeloproliferative neoplasms. Currently, he is the Vicepresident of the Grupo Español de Neoplasias Mieloproliferativas Filadelfia Negativas (GEMFIN). As a result of his scientific activity in these fields, he has published around 70 papers in peer-review international journals.